Streetbeat News

TRMD

TORM plc

https://www.torm.com

Industry

Oil & Gas Midstream

TORM plc, a product tanker company, engages in the transportation of refined oil products and crude oil worldwide. The company transports gasoline, jet fuel, and naphtha. As of March 23, 2022, it operated a fleet of approximately 85 vessels. The company was founded in 1889 and is headquartered in London, the United Kingdom.

Open

24.90

Mkt cap

2.4B

Volume

2.1M

High

25.55

P/E Ratio

3.17

52-wk high

40.47

Low

24.64

Div yield

0.19

52-wk low

24.06

Oil and gas company shares are declining due to an increase in US crude inventories.

Portfolio Pulse from Benzinga Newsdesk

October 23, 2024 | 7:26 pm

The article highlights two oversold energy stocks, Ecopetrol SA and Torm PLC, which present potential buying opportunities. Ecopetrol's stock has fallen significantly following a cash tender offer announcement, while Torm's stock has declined despite a positive analyst rating.

Portfolio Pulse from Avi Kapoor

October 18, 2024 | 12:05 pm

Cassava Sciences and enVVeno Medical are among the big stocks moving lower in Friday's pre-market session. Cassava Sciences fell due to SEC charges, while enVVeno Medical dropped after announcing a public offering.

Portfolio Pulse from Avi Kapoor

September 27, 2024 | 12:47 pm

The article highlights four energy stocks with low RSI values, indicating they are oversold and may present buying opportunities. These stocks include Vital Energy Inc (VTLE), Torm PLC (TRMD), New Fortress Energy Inc (NFE), and Gulf Island Fabrication, Inc. (GIFI).

Portfolio Pulse from Avi Kapoor

September 06, 2024 | 11:32 am

Oil and gas company shares are declining due to reports of a potential deal to restart Libyan oil production and exports.

Portfolio Pulse from Benzinga Newsdesk

September 03, 2024 | 2:33 pm

Jim Cramer discussed several stocks on CNBC's 'Mad Money Lightning Round,' including TORM plc, Trane Technologies, Axsome Therapeutics, and SAP SE. He highlighted TORM's high dividend yield, recommended buying Trane Technologies and SAP, and described Axsome Therapeutics as a high-risk, high-reward stock. Analysts have recently provided ratings and price targets for these companies.

Portfolio Pulse from Avi Kapoor

July 24, 2024 | 1:25 pm

Evercore ISI Group analyst Jonathan Chappell maintains an Outperform rating on TORM (NASDAQ:TRMD) and raises the price target from $45 to $48.

Portfolio Pulse from Benzinga Newsdesk

July 23, 2024 | 4:37 pm

Marinus Pharmaceuticals, Inc. (NASDAQ:MRNS) shares plummeted 74.2% in pre-market trading after updating on the Phase 3 RAISE Trial and reporting preliminary Q1 2024 financial results with ZTALMY net revenue of $7.4 to $7.6 million. Other stocks also moved lower in pre-market trading: Neumora Therapeutics, Inc. (NASDAQ:NMRA) dropped 17.1% due to an FDA clinical hold, Roadzen, Inc. (NASDAQ:RDZN) fell 14%, Ultragenyx Pharmaceutical Inc. (NASDAQ:RARE) declined 11.4% after interim Phase 1/2 data, Cogent Biosciences, Inc. (NASDAQ:COGT) decreased 7.7%, Polestar Automotive Holding UK PLC (NASDAQ:PSNY) dropped 7.2%, Molina Healthcare, Inc. (NYSE:MOH) fell 7.1%, and TORM plc (NASDAQ:TRMD) slipped 3.1%.

Portfolio Pulse from Avi Kapoor

April 15, 2024 | 12:19 pm

Evercore ISI Group has reaffirmed its Outperform rating on TORM (NASDAQ:TRMD) and increased its price target from $42.00 to $44.00. Despite a 0.9% decline in TORM's share price over the last 24 hours to $32.90, the new price target suggests a potential upside of 33.74%. TORM PLC is a shipping company specializing in the transportation of refined oil products.

Portfolio Pulse from Benzinga Insights

March 08, 2024 | 5:00 pm

Evercore ISI Group analyst Jonathan Chappell has maintained an Outperform rating on TORM (NASDAQ:TRMD) and increased the price target from $42 to $44.

Portfolio Pulse from Benzinga Newsdesk

March 08, 2024 | 3:25 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.